FindTrial
Sign In

The risk of adverse pregnancy outcome in subclinical hypothyroidism when compared to euthyroid women

Comparison of Pregnancy outcome in subclinical hypothyroidism (TSH levels between 2.5 - 4mIU/L) with euthyroid women -A Prospective cohort study

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2020/09/028144
Enrollment
173
Registered
2020-09-29
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: E039- Hypothyroidism, unspecified

Interventions

None listed

Sponsors

JIPMER
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1 TSH levels 0.1 -4 mIU/L 2

Exclusion criteria

Exclusion criteria: â?? History of thyroid disorder â?? Medications for hypo/hyperthyroidism â?? Presence of goiter â?? Overt diabetes mellitus â?? Chronic hypertension

Design outcomes

Primary

MeasureTime frame
. To compare pregnancy outcome between subclinical hypothyroidism (TSH between levels 2.5 - 4 mIU/L ) and euthyroid women . Timepoint: baseline,on admission for pregnancy related complications or during labour , after delivery—

Secondary

MeasureTime frame
1. To find out the proportion of women with subclinical hypothyroidism having thyroid peroxidase antibodies. 2.To compare the pregnancy outcome between thyroid peroxidase antibodies positive and negative groups in women with subclinical hypothyroidism (TSH levels between 2.5 -4 mIU/L). Timepoint: baseline, after delivery—

Countries

India

Contacts

Public ContactDr Haritha Sagili

JIPMER

harithasagili@gmail.com9489390630

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026